Introduction
This article highlights those pure-play clinical stage biotech stocks that are embracing AI to streamline drug discovery and development because creating a new drug using AI can help a company, in some cases, develop a new drug in a matter of days instead of the years it might take using the traditional clinical trial approach. Below are how the 5 constituents have performed YTD and the reasons why:
Constituents:
- Absci Corporation (ABSI): UP 122.1% YTD
- Recursion Pharmaceuticals (RXRX): UP 55.8% YTD
- Schrödinger (SDGR): UP 28.8% YTD
- AbCellera Biologics (ABCL): UP 11.6%YTD
- Relay Therapeutics (RLAY): DOWN 2.9% YTD
The MunAiMarkets Ai-focused Drug Discovery Stocks Portfolio is UP 35.7% YTD!
Click on the links provided below to access specific information on each constituent:
-
Portfolio Performance:
-
To determine the current Portfolio Performance at any time during the Day go HERE (see “Today’s Gain” in top left-hand corner).
-
To determine the historical Portfolio YTD, 1M, 6M and 1Y Performance, go HERE, Add Portfolio Symbols, Scroll Down to “Portfolio Performance Settings” & Click on “Calculate Performance”, Scroll Down to “Portfolio Performance Chart” & Specify “Time Period” and Scroll Down to “Returns by Period”. Here’s an example.
-
-
Constituent Stock Performances:
-
Constituent Statistics:
-
Go HERE, type in Stock Symbol, and Click on Statistics
-
-
Constituent Financials:
-
go HERE, type in Stock Symbol, and Click on Financial
-